NUCLEA BIOTECHNOLOGIES, INC. – Trademark Portfolio

Entity Type: 03

NUCLEA BIOTECHNOLOGIES, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in PITTSFIELD, MA.

46 ELM STREET

PITTSFIELD, MA 01201

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NUCLEA BIOTECHNOLOGIES, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does NUCLEA BIOTECHNOLOGIES, INC. have?

NUCLEA BIOTECHNOLOGIES, INC. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does NUCLEA BIOTECHNOLOGIES, INC. file in?

NUCLEA BIOTECHNOLOGIES, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is NUCLEA BIOTECHNOLOGIES, INC.'s trademark registration success rate?

NUCLEA BIOTECHNOLOGIES, INC. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.